Cranial electrotherapy stimulation (CES) is a non-invasive intervention to treat anxiety, depression, insomnia, and pain. But clinical studies and applications of CES in relation to acute postoperative pain are few. tThe investigators investigate a double-blind, randomized controlled trial to figure out if intraoperative CES could decrease dosage of intraoperative anesthetics and patient-controlled analgesia (PCA) consumption in patients undergoing colon cancer surgery.
Cranial electrotherapy stimulation (CES) is a non-invasive and safe intervention, transmitting microcurrents of brain stimulation and releasing various neurotransmitters such as endorphin and downstream hormones to modulate autonomic nervous system, as a result, for treating anxiety, depression, insomnia, and pain. Acute postoperative pain annoys patients receiving surgery. Once acute postoperative pain is poorly controlled, it may result in adverse acute effects (i.e., physiologic and psychologic stress), chronic effects (i.e., delayed long-term recovery and chronic pain), and, in consequence, excess length of hospitalization and extra costs. Besides, inflammatory reactions mediated by immune system are formed after tissue injury (e.g. trauma, surgery, etc), release serial inflammatory cytokines and are related to pain signal transmission. However, clinical studies and applications of CES focus on management of chronic pain, modulation of mood and insomnia rather than acute postoperative pain in recent years. The investigators investigate a double-blind, randomized controlled trial to figure out if intraoperative CES could decrease dosage of intraoperative anesthetics and patient-controlled analgesia (PCA) consumption in patients undergoing colon cancer surgery. The investigators also collect blood samples before and after surgery for analysis of serum cytokines. Meanwhile, Bispectral IndexTM (BISTM) monitoring and Analgesia Nociception Index (ANI) are prescribed during the surgery not only for measuring of the effects of anesthetics and sedatives on the brain, but also evaluating perioperative analgesia. Thereby, the effectiveness of CES for management of acute postoperative pain may introduce clinicians for alternative application of pain control after surgery in the future.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
Cranial electrotherapy stimulation
consumption of opioids during general anesthesia
laparoscopic colon cancer surgery
TriService General Hospital
Taipei, Taiwan
RECRUITINGdosage of intraoperative anesthetics
The consumption of total amount of supplemental analgesics administered during colon cancer surgery
Time frame: during surgery
Rescue analgesics
The consumption of total amount of rescue analgesics administered after colon cancer surgery
Time frame: from the end of the surgery to postoperative 72 hours
Differences in Pain Intensity Between CES intervention and the control group
Pain assessment of NRS pain intensity scores and patient satisfaction assessed by the NRS through end of surgery to postoperative 72 hours
Time frame: from the end of the surgery to postoperative 72 hours
dosage of patient-controlled analgesia (PCA) consumption
postoperative PCA consumption
Time frame: from the end of the surgery to postoperative 72 hours
serum concentration of serum cytokine
proinflammatory and antiinflammatory cytokines (IL-1a, IL-2, IL-6, IL-7, TNF-a, IL-4, IL-10, IL-10, IL-1, TGF-b)
Time frame: from the beginning of the surgery to postoperative 72 hours
Number of Participants with CES and control groups
patient characteristics
Time frame: during surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
TREATMENT
Masking
SINGLE
Enrollment
80